Stocktoria
Axsome Therapeutics, Inc. AXSM
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2015-11-19
Axsome Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 3,299,991 | $265.6M |
| D. E. Shaw & Co., Inc. | 607,165 | $102.6M |
| Point72 Asset Management, L.P. | 424,750 | $71.8M |
| CITADEL ADVISORS LLC | 421,003 | $71.2M |
| TWO SIGMA INVESTMENTS, LP | 326,478 | $55.2M |
| RENAISSANCE TECHNOLOGIES LLC | 164,300 | $27.8M |
| AQR CAPITAL MANAGEMENT LLC | 104,059 | $17.6M |
| Bridgewater Associates, LP | 56,951 | $9.6M |
Source: SEC EDGAR filings · CIK 0001579428 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.